[Experts' Opinion] Novel formulations of docetaxel, paclitaxel and doxorubicin in the management of metastatic breast cancer-Reference-Cited by-同舟云学术

[Experts' Opinion] Novel formulations of docetaxel, paclitaxel and doxorubicin in the management of metastatic breast cancer

Published:2018-07-02 Issue: Volume: Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Rajappa Senthil¹,Joshi Ashish²,Doval Dinesh³,Batra Ullas³,Rajendranath Rejiv⁴,Deo Avinash⁵,Biswas Ghanshyam⁶,Bajpai Peush⁷,Tilak T.⁸,Kane Sriram⁹,Kumar Kishore⁸,Kumar Manish¹⁰,Talele Avinash¹¹,Devde Prakash¹²,Gupta Ashutosh¹³,Joshi Nisarg¹⁴,Sejpal Jaykumar¹⁴,Bunger Deepak¹⁴,Khan Mujtaba¹⁴

Affiliation:

1. Department of Medical Oncology, Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, Telangana 500034, India

2. Nanavati Hospital, Mumbai, Maharashtra 400056, India

3. Rajiv Gandhi Cancer Institute and Research Centre, Delhi 110085, India

4. Apollo Speciality Hospital, Chennai, Tamil Nadu 600096, India

5. Fortis SL Raheja Hospital, Mumbai, Maharashtra 400016, India

6. Sparsh Hospital, Bhubaneswar, Odisha 751007, India

7. Max Super Speciality Hospital, New Delhi 110017, India

8. Command Hospital, Bangalore, Karnataka 560007, India

9. Kane Hematology and Oncology Clinic, Nagpur, Maharashtra 440012, India

10. Command Hospital, Lucknow, Uttar Pradesh 226002, India

11. CHL Hospital, Indore, Madhya Pradesh 452008, India